1. Accueil
  2. Publications
  3. endTB-Q trial: a caveat on confounding by baseline drug resistance - Authors' reply.

endTB-Q trial: a caveat on confounding by baseline drug resistance - Authors' reply.

Guglielmetti L Gouillou M Rupasinghe P Mitnick CD
The Lancet. Respiratory medicine 2026 May 15; . doi: 10.1016/S2213-2600(26)00152-9. Epub 2026 05 15

Lien vers la page de l'article